Squawk Pod: AI “Genies” & Hims & Hers CEO Andrew Dudum - 08/18/26 | Audio Only

Summary

The episode features two interviews: Genies CEO Akash Nigam demonstrates AI avatar personas and argues AI personalities need stylized faces, while Hims & Hers CEO Andrew Dudum lays out an AI-native, consumer-first healthcare vision spanning GLP-1 disruption, peptides, proactive genetic testing, and global expansion. The hosts also cover Meta's social media trial, Anthropic's IPO preparations, and Lakers ownership drama. Main market implications include regulatory overhang on Meta, AI ecosystem growth, and healthcare disruption favoring HIMS while pressuring branded GLP-1 drug pricing.

• Meta faces a landmark social media addiction trial with large potential damages and product-change risk.
• Anthropic reports a $65B annualized revenue run rate and may be moving toward a massive IPO.
• Genies shows an AI avatar of Becky Quick and argues future internet surfaces need AI personalities with stylized visuals.
• Hims & Hers CEO details an AI-native platform, in-house AI, and closed-loop patient data advantage.
• Dudum says GLP-1 prices could fall to $40-$50 monthly by 2030 on competition and patent expiry.
• Dudum sees peptides, proactive genetic testing, and global expansion as key HIMS growth areas.
• The Lakers Buss family control dispute may head to settlement or court.